Not applicableUnknownNCT01538264What this trial is testingBlood Flow MRI for Monitoring Brain TumorsWho this might be right forBrain Tumors Beth Israel Deaconess Medical Center 125
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT03162588What this trial is testingMultiple Burrhole Therapy With Erythropoietin for Unstable MoyamoyaWho this might be right forIschemic AttackIschemic StrokeMoyamoya Disease+2 more Ajou University School of Medicine 37
Testing effectiveness (Phase 2)Study completedNCT00271609What this trial is testingBevacizumab for Recurrent Malignant GliomaWho this might be right forRecurrent High-Grade GliomasMalignant Gliomas National Cancer Institute (NCI) 88
Not applicableWithdrawnNCT00005790What this trial is testingPerfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00667394What this trial is testingTandutinib Plus Bevacizumab to Treat Recurrent Brain TumorsWho this might be right forGlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more National Cancer Institute (NCI) 42
Not applicableStudy completedNCT02157896What this trial is testingVascular Endothelial Growth Factor and Endostatin in Angiogenesis After Acute Ischemic StrokeWho this might be right forAcute Ischemic Stroke Shanghai 6th People's Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT02995642What this trial is testingTargeted PET/CT and PET/MRI Imaging of Vascular InflammationWho this might be right forAortic Aneurysm, AbdominalCarotid Atherosclerosis Stanford University
Early research (Phase 1)Study completedNCT01468324What this trial is testingAZD7451 for Recurrent GliomasWho this might be right forGlioblastoma Multiforme National Cancer Institute (NCI) 14
Not applicableStudy completedNCT01819597What this trial is testingSurgical Indirect Revascularization For Symptomatic Intracranial Arterial StenosisWho this might be right forIntracranial Arterial StenosisIntracranial AtherosclerosisIschemic Stroke+1 more Cedars-Sinai Medical Center 52
Testing effectiveness (Phase 2)Ended earlyNCT00476827What this trial is testingA Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to BrainWho this might be right forBreast Cancer Duke University 16
Testing effectiveness (Phase 2)Study completedNCT01806675What this trial is testing18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT01028794What this trial is testingAutologous Bone Marrow Mononuclear Cell Transplantation for Stroke PatientsWho this might be right forCerebral EmbolismStroke National Cerebral and Cardiovascular Center, Japan 12
Testing effectiveness (Phase 2)Study completedNCT01753713What this trial is testingDovitinib in Treating Patients With Recurrent or Progressive GlioblastomaWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more Manmeet Ahluwalia, MD 33
Not applicableStudy completedNCT04566185What this trial is testingEvaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent GlioblastomaWho this might be right forGlioblastoma Centre Hospitalier Universitaire de Nīmes 14
Not applicableStudy completedNCT00064909What this trial is testingMR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple SclerosisWho this might be right forMultiple Sclerosis National Institutes of Health Clinical Center (CC) 50
Testing effectiveness (Phase 2)Study completedNCT00036569What this trial is testingA Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine GliomasWho this might be right forDiffuse Intrinsic Pontine Glioma National Cancer Institute (NCI) 32
Large-scale testing (Phase 3)Looking for participantsNCT06264531What this trial is testingEfficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous MalformationsWho this might be right forCerebral AV Malformation Fondation Ophtalmologique Adolphe de Rothschild 54
Not applicableEnrolling By InvitationNCT04240119What this trial is testingAngiogenic Markers in Cerebrovascular Disease (ANFIS)Who this might be right forStrokeTransient Ischemic AttackAtherosclerosis+2 more Cedars-Sinai Medical Center 300
Not applicableStudy completedNCT00010114What this trial is testingGenetic Study of Newly Diagnosed Central Nervous System Tumors in Young ChildrenWho this might be right forCentral Nervous System Embryonal Neoplasm Pediatric Brain Tumor Consortium 83